340570 — T&L Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapContrarian

Annual income statement for T&L Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	40,633	71,896	81,577	115,461	174,892
Cost of Revenue
Gross Profit	15,808	30,515	34,208	45,153	75,493
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	31,041	49,569	57,268	84,622	117,934
Operating Profit	9,592	22,327	24,309	30,839	56,957
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	11,475	23,432	25,561	33,060	62,287
Provision for Income Taxes
Net Income After Taxes	10,042	19,585	21,118	27,439	46,408
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	10,042	19,585	21,118	27,439	46,408
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	10,042	19,585	21,118	27,439	46,408
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,512	2,409	2,602	3,399	5,749
Dividends per Share